Berkley Capital, Llc Sells 373,500 Shares of HealthEquity, Inc. (HQY) Stock

HealthEquity, Inc. (NASDAQ:HQY) major shareholder Berkley Capital, Llc sold 373,500 shares of the business’s stock in a transaction that occurred on Monday, November 6th. The stock was sold at an average price of $53.21, for a total value of $19,873,935.00. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Major shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.

Berkley Capital, Llc also recently made the following trade(s):

  • On Thursday, November 2nd, Berkley Capital, Llc sold 13,600 shares of HealthEquity stock. The stock was sold at an average price of $51.02, for a total value of $693,872.00.
  • On Thursday, October 12th, Berkley Capital, Llc sold 11,395 shares of HealthEquity stock. The stock was sold at an average price of $51.91, for a total value of $591,514.45.
  • On Monday, October 9th, Berkley Capital, Llc sold 1,100 shares of HealthEquity stock. The stock was sold at an average price of $51.95, for a total value of $57,145.00.
  • On Friday, October 6th, Berkley Capital, Llc sold 29,032 shares of HealthEquity stock. The stock was sold at an average price of $51.97, for a total value of $1,508,793.04.
  • On Thursday, October 5th, Berkley Capital, Llc sold 286,512 shares of HealthEquity stock. The stock was sold at an average price of $51.96, for a total value of $14,887,163.52.

Shares of HealthEquity, Inc. (NASDAQ:HQY) opened at $49.31 on Wednesday. The firm has a market capitalization of $3,263.97, a price-to-earnings ratio of 85.65, a PEG ratio of 2.37 and a beta of 1.77. HealthEquity, Inc. has a 1 year low of $30.36 and a 1 year high of $55.31.

HealthEquity (NASDAQ:HQY) last released its earnings results on Tuesday, September 5th. The company reported $0.27 earnings per share for the quarter, beating analysts’ consensus estimates of $0.14 by $0.13. The firm had revenue of $56.90 million during the quarter, compared to the consensus estimate of $55.66 million. HealthEquity had a return on equity of 13.93% and a net margin of 20.27%. The company’s revenue was up 28.7% compared to the same quarter last year. During the same period in the prior year, the company posted $0.16 EPS. equities analysts expect that HealthEquity, Inc. will post 0.7 EPS for the current year.

WARNING: This piece was originally reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of international copyright & trademark legislation. The legal version of this piece can be viewed at https://sportsperspectives.com/2017/11/08/berkley-capital-llc-sells-373500-shares-of-healthequity-inc-hqy-stock.html.

Several large investors have recently added to or reduced their stakes in HQY. Oppenheimer Asset Management Inc. bought a new stake in shares of HealthEquity during the 1st quarter valued at $106,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of HealthEquity by 105.8% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,544 shares of the company’s stock valued at $127,000 after acquiring an additional 1,308 shares during the period. Riverhead Capital Management LLC lifted its position in shares of HealthEquity by 75.3% during the 2nd quarter. Riverhead Capital Management LLC now owns 2,629 shares of the company’s stock valued at $131,000 after acquiring an additional 1,129 shares during the period. Exane Derivatives bought a new stake in shares of HealthEquity during the 2nd quarter valued at $132,000. Finally, Fortaleza Asset Management Inc. acquired a new position in shares of HealthEquity during the 2nd quarter worth $138,000. Hedge funds and other institutional investors own 91.40% of the company’s stock.

Several analysts recently issued reports on HQY shares. BidaskClub downgraded HealthEquity from a “buy” rating to a “hold” rating in a research note on Monday, July 24th. Zacks Investment Research upgraded HealthEquity from a “hold” rating to a “buy” rating and set a $54.00 price target for the company in a research note on Wednesday, July 12th. TheStreet upgraded HealthEquity from a “c” rating to a “b” rating in a research note on Monday, July 31st. Cantor Fitzgerald restated a “buy” rating and issued a $56.00 price target on shares of HealthEquity in a research note on Tuesday, September 5th. Finally, Robert W. Baird restated a “hold” rating on shares of HealthEquity in a research note on Thursday, September 21st. Two analysts have rated the stock with a hold rating and nine have given a buy rating to the company. HealthEquity has a consensus rating of “Buy” and a consensus target price of $57.50.

HealthEquity Company Profile

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Insider Buying and Selling by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply